Creative Planning’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $615K | Sell |
25,745
-1,364
| -5% | -$32.6K | ﹤0.01% | 2269 |
|
2025
Q1 | $674K | Buy |
27,109
+2,463
| +10% | +$61.2K | ﹤0.01% | 2033 |
|
2024
Q4 | $464K | Buy |
24,646
+8,577
| +53% | +$162K | ﹤0.01% | 2290 |
|
2024
Q3 | $242K | Buy |
16,069
+7,795
| +94% | +$117K | ﹤0.01% | 2702 |
|
2024
Q2 | $237K | Buy |
+8,274
| New | +$237K | ﹤0.01% | 2538 |
|
2023
Q4 | – | Sell |
-62
| Closed | -$1.9K | – | 2935 |
|
2023
Q3 | $1.9K | Buy |
+62
| New | +$1.9K | ﹤0.01% | 2747 |
|
2023
Q2 | – | Sell |
-5
| Closed | -$205 | – | 2649 |
|
2023
Q1 | $205 | Buy |
+5
| New | +$205 | ﹤0.01% | 2519 |
|
2018
Q2 | – | Sell |
-9,050
| Closed | -$282K | – | 1970 |
|
2018
Q1 | $282K | Buy |
+9,050
| New | +$282K | ﹤0.01% | 1366 |
|
2017
Q3 | – | Sell |
-1,600
| Closed | -$76K | – | 3088 |
|
2017
Q2 | $76K | Hold |
1,600
| – | – | ﹤0.01% | 2172 |
|
2017
Q1 | $73K | Hold |
1,600
| – | – | ﹤0.01% | 2154 |
|
2016
Q4 | $52K | Hold |
1,600
| – | – | ﹤0.01% | 2346 |
|
2016
Q3 | $55K | Hold |
1,600
| – | – | ﹤0.01% | 2268 |
|
2016
Q2 | $54K | Hold |
1,600
| – | – | ﹤0.01% | 2079 |
|
2016
Q1 | $85K | Sell |
1,600
-100
| -6% | -$5.31K | ﹤0.01% | 1718 |
|
2015
Q4 | $131K | Buy |
1,700
+600
| +55% | +$46.2K | ﹤0.01% | 1471 |
|
2015
Q3 | $45K | Buy |
+1,100
| New | +$45K | ﹤0.01% | 2108 |
|
2015
Q2 | – | Sell |
-1,100
| Closed | -$98K | – | 2332 |
|
2015
Q1 | $98K | Buy |
1,100
+100
| +10% | +$8.91K | ﹤0.01% | 1571 |
|
2014
Q4 | $89K | Sell |
1,000
-50
| -5% | -$4.45K | ﹤0.01% | 1597 |
|
2014
Q3 | $102K | Buy |
1,050
+50
| +5% | +$4.86K | ﹤0.01% | 1452 |
|
2014
Q2 | $92K | Hold |
1,000
| – | – | ﹤0.01% | 1476 |
|
2014
Q1 | $70K | Sell |
1,000
-2,002
| -67% | -$140K | ﹤0.01% | 1602 |
|
2013
Q4 | $173K | Hold |
3,002
| – | – | ﹤0.01% | 933 |
|
2013
Q3 | $144K | Hold |
3,002
| – | – | ﹤0.01% | 912 |
|
2013
Q2 | $87K | Buy |
+3,002
| New | +$87K | ﹤0.01% | 1061 |
|